<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2 20190208//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName A++V2.4.dtd?><?SourceDTD.Version 2.4?><?ConverterInfo.XSLTName springer2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Sci Rep</journal-id><journal-id journal-id-type="iso-abbrev">Sci Rep</journal-id><journal-title-group><journal-title>Scientific Reports</journal-title></journal-title-group><issn pub-type="epub">2045-2322</issn><publisher><publisher-name>Nature Publishing Group UK</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">6592948</article-id><article-id pub-id-type="publisher-id">45686</article-id><article-id pub-id-type="doi">10.1038/s41598-019-45686-y</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Purification and characterization of a novel, highly potent fibrinolytic enzyme from <italic>Bacillus subtilis</italic> DC27 screened from <italic>Douchi</italic>, a traditional Chinese fermented soybean food</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><name><surname>Hu</surname><given-names>Yuanliang</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Yu</surname><given-names>Dan</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Zhaoting</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Hou</surname><given-names>Jianjun</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Tyagi</surname><given-names>Rohit</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Liang</surname><given-names>Yunxiang</given-names></name><address><email>fa-lyx@163.com</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Hu</surname><given-names>Yongmei</given-names></name><address><email>plum73@163.com</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1790 4137</institution-id><institution-id institution-id-type="GRID">grid.35155.37</institution-id><institution>State Key Laboratory of Agricultural Microbiology, College of Life Science and Technology, Huazhong Agricultural University, </institution></institution-wrap>Wuhan, 430070 China </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2185 8047</institution-id><institution-id institution-id-type="GRID">grid.462271.4</institution-id><institution>Hubei Key Laboratory of Edible Wild Plants Conservation&#x00026; Utilization, College of Life Sciences, Hubei Normal University, </institution></institution-wrap>Huangshi, 435002 China </aff><aff id="Aff3"><label>3</label>Hubei Collaborative Innovation Center for Industrial Fermentation, Wuhan, 430068 China </aff></contrib-group><pub-date pub-type="epub"><day>25</day><month>6</month><year>2019</year></pub-date><pub-date pub-type="pmc-release"><day>25</day><month>6</month><year>2019</year></pub-date><pub-date pub-type="collection"><year>2019</year></pub-date><volume>9</volume><elocation-id>9235</elocation-id><history><date date-type="received"><day>20</day><month>12</month><year>2018</year></date><date date-type="accepted"><day>30</day><month>5</month><year>2019</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2019</copyright-statement><license license-type="OpenAccess"><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article&#x02019;s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article&#x02019;s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p></license></permissions><abstract id="Abs1"><p id="Par1">The highly fibrinolytic enzyme-producing bacterium was identified as <italic>Bacillus subtilis</italic> DC27 and isolated from <italic>Douchi</italic>, a traditional fermented soybean food. The DFE27 enzyme was purified from the fermentation broth of <italic>B</italic>. <italic>subtilis</italic> DC27 by using UNOsphere Q column chromatography, Sephadex G-75 gel filtration, and high-performance liquid chromatography. It was 29&#x02009;kDa in molecular mass and showed the optimal reaction temperature and pH value of 45&#x02009;&#x000b0;C and 7.0, respectively, with a stable fibrinolytic activity below 50&#x02009;&#x000b0;C and within the pH range of 6.0 to 10.0. DFE27 was identified as a serine protease due to its complete inhibition by phenylmethysulfony fluoride. The first 24 amino acid residues of the N-terminal sequence of the enzyme were AQSVPYGVSQIKAPALHSQGFTGS. The enzyme displayed the highest specificity toward the substrate D-Val-Leu-Lys-pNA for plasmin and it could not only directly degrade but also hydrolyze fibrin by activating plasminogen into plasmin. Overall, the DFE27 enzyme was obviously different from other known fibrinolytic enzymes in the optimum substrate specificity or fibrinolytic action mode, suggesting that it is a novel fibrinolytic enzyme and may have potential applications in the treatment and prevention of thrombosis.</p></abstract><kwd-group kwd-group-type="npg-subject"><title>Subject terms</title><kwd>Proteases</kwd><kwd>Bacterial genomics</kwd><kwd>RNA sequencing</kwd><kwd>Applied microbiology</kwd></kwd-group><funding-group><award-group><funding-source><institution>Hubei Key Laboratory of Edible Wild Plants Conservation and Utilization,EWPL201707</institution></funding-source></award-group></funding-group><funding-group><award-group><funding-source><institution>the State Key Laboratory of Agricultural Microbiology,AMLKF201708</institution></funding-source></award-group></funding-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">https://doi.org/10.13039/501100001809</institution-id><institution>National Natural Science Foundation of China (National Science Foundation of China)</institution></institution-wrap></funding-source><award-id>31300042</award-id><principal-award-recipient><name><surname>Hu</surname><given-names>Yuanliang</given-names></name></principal-award-recipient></award-group></funding-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; The Author(s) 2019</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1" sec-type="introduction"><title>Introduction</title><p id="Par2">Currently, cardiovascular diseases (CVDs) are dominant causes of death worldwide for people with hypertension, myocardial infarct, coronary heart disease, or stenocardia<sup><xref ref-type="bibr" rid="CR1">1</xref></sup>. Consistent with the estimation of World Health Organization(WHO), CVDs caused 15.6 million deaths in 2010 worldwide and are expected to cause more than 20 million deaths per year by 2020<sup><xref ref-type="bibr" rid="CR2">2</xref>,<xref ref-type="bibr" rid="CR3">3</xref></sup>. In the various types of CVDs, thrombosis is among the most commonly occurring diseases of modern life and could be responsible for the increasing number of deaths<sup><xref ref-type="bibr" rid="CR4">4</xref>,<xref ref-type="bibr" rid="CR5">5</xref></sup>.</p><p id="Par3">The fibrinolytic system can not only dissolve fibrin clots resulting from fibrinogen through activated thrombin (EC 3.4.21.5), but also provide a channel for blood flow at the site of vascular injury as hemostatic response<sup><xref ref-type="bibr" rid="CR6">6</xref>,<xref ref-type="bibr" rid="CR7">7</xref></sup>. Additionally, the plasmin also hydrolyzes fibrin clots at the site of injury (EC 3.4.21.7) to prevent thrombosis<sup><xref ref-type="bibr" rid="CR2">2</xref></sup>. The clots which are not hydrolyzed lead to the occurrence of thrombosis under unstable conditions like myocardial infraction or disorders such as hypertension<sup><xref ref-type="bibr" rid="CR8">8</xref></sup>.</p><p id="Par4">The most effective drugs for treating thrombosis are fibrinolytic enzymes, which can be divided into two types according to their action mode: plasminogen activators (PAs), including tissue plasminogen activator (t-PA), streptokinase (SK, 3.4.99.22) and urokinase (UK, EC 3.4.21.31), which can lyse fibrin through the formation of plasmin from plasminogen<sup><xref ref-type="bibr" rid="CR9">9</xref>,<xref ref-type="bibr" rid="CR10">10</xref></sup>, and plasmin-like fibrinolytic enzymes, which can degrade the fibrin directly<sup><xref ref-type="bibr" rid="CR2">2</xref></sup>. Despite extensive research about them and their wide use as thrombolytic agents, these PAs are high in price and low in specificity, prompting the researchers to explore for safer and cheaper resources. Microorganisms contribute to the production and use of the fibrinolytic enzymes since ancient times, and researchers have paid increasing attention to the production of fibrinolytic enzymes by microorganisms, particularly those from the food sources. During past decades, several fibrinolytic enzymes have been recognized from different microorganisms, especially the genus <italic>Bacillus</italic><sup><xref ref-type="bibr" rid="CR5">5</xref>,<xref ref-type="bibr" rid="CR11">11</xref>&#x02013;<xref ref-type="bibr" rid="CR14">14</xref></sup>.</p><p id="Par5">Recent studies have shown that various potent fibrinolytic enzymes can be produced from different kinds of traditional fermented foods, for example, Japanese <italic>natto</italic><sup><xref ref-type="bibr" rid="CR15">15</xref></sup>, Chinese fermented paste<sup><xref ref-type="bibr" rid="CR16">16</xref></sup>, fermented red bean<sup><xref ref-type="bibr" rid="CR17">17</xref></sup>, <italic>Douchi</italic><sup><xref ref-type="bibr" rid="CR4">4</xref>,<xref ref-type="bibr" rid="CR5">5</xref>,<xref ref-type="bibr" rid="CR18">18</xref>,<xref ref-type="bibr" rid="CR19">19</xref></sup>, <italic>Doenjang</italic><sup><xref ref-type="bibr" rid="CR13">13</xref>,<xref ref-type="bibr" rid="CR20">20</xref></sup>, <italic>cheonggukjan</italic>g<sup><xref ref-type="bibr" rid="CR21">21</xref></sup>, Indonesian <italic>tempeh</italic><sup><xref ref-type="bibr" rid="CR12">12</xref></sup>, and Egyptian <italic>Kishk</italic><sup><xref ref-type="bibr" rid="CR14">14</xref></sup>. It has been confirmed that Nattokinase (NK) can directly lyse thrombi <italic>in vivo</italic> and its oral administration can improve plasma fibrinolytic activity as well as t-PA production<sup><xref ref-type="bibr" rid="CR22">22</xref>&#x02013;<xref ref-type="bibr" rid="CR24">24</xref></sup>. Similar fibrinolytic enzymes from <italic>Douchi</italic> were also confirmed to degrade fibrin directly and efficiently in <italic>vitro</italic> and in <italic>vivo</italic><sup><xref ref-type="bibr" rid="CR5">5</xref>,<xref ref-type="bibr" rid="CR25">25</xref></sup>. In this article, a novel enzyme with potential fibrinolytic activity was isolated, purified and characterized from the bacterial strain <italic>B</italic>. <italic>subtilis</italic> DC27 in <italic>Douchi</italic>, a fermented soybean food popular in China since ancient times.</p></sec><sec id="Sec2" sec-type="materials|methods"><title>Materials and Methods</title><sec id="Sec3"><title>Isolation and identification of bacterial strain</title><p id="Par6">The dry <italic>Douchi</italic> samples obtained from Jiatai Co., Ltd., Chongqing, China were soaked in sterile saline for 20&#x02009;min at 37&#x02009;&#x000b0;C, treated at 80&#x02009;&#x000b0;C for 10&#x02009;min, and isolated by serial dilution in sterile saline. After centrifugation at 4,000&#x02009;rpm for 5&#x02009;min, the culture supernatants were cultured on the nutrient agar broth containing casein at 37&#x02009;&#x000b0;C for 18&#x02009;h, followed by collecting the single colonies and culture in Luria-Bertani medium at 37&#x02009;&#x000b0;C for 72&#x02009;h under shaking.</p><p id="Par7">The physiological and biochemical characteristics of the isolates were identified as described in the Bergey&#x02019;s Brochure for identification of Bacteriology. The extraction of total genomic DNA was performed using the Genomic Tip-100 kit (Qiagen, Hilden, Germany) for 16&#x02009;S rDNA identification, and the gene was PCR amplified using primers of 5&#x02032;-AGAGTTTGATCCTGGCTCAG-3&#x02032; and 5&#x02032;-ACGGCTACCTTGTTACGACT-3&#x02032;&#x02009;<sup><xref ref-type="bibr" rid="CR26">26</xref></sup>. The 16S rDNA sequence homology analysis was performed using the basic local alignment search tool (BLAST) at the website of NCBI (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov">http://www.ncbi.nlm.nih.gov</ext-link>).</p></sec><sec id="Sec4"><title>Fibrinolytic activity assay</title><p id="Par8">A minorly modified fibrin plate method was used to determine the fibrinolytic activity<sup><xref ref-type="bibr" rid="CR27">27</xref></sup>. Specifically, 0.15% fibrinogen (bovine; NICPBP, Beijing, China) was mixed with 10&#x02009;ml of 60&#x02009;mM sodium phosphate buffer (pH 7.4), and 1&#x02009;ml of thrombin (bovine; NICPBP, Beijing, China) (5 U ml<sup>&#x02212;1</sup>) was dissolved in 10&#x02009;ml of 1.5% agarose gel. Next, the two solutions were well mixed and poured into the plates, followed by treatment at 37&#x02009;&#x000b0;C for 30&#x02009;min to allow the formation of fibrin clots, and punching nine holes on fibrin coagulum by a duchenne tubular (diameter 2&#x02009;mm). After heating at 80&#x02009;&#x000b0;C for 30&#x02009;min to inactivate the plasminogen (bovine; NICPBP, Beijing, China), the plates were supplemented with 10 &#x003bc;l of enzyme solutions through the 9 punched holes and then incubated at 37&#x02009;&#x000b0;C for 18&#x02009;h. The fibrinolytic enzyme activity was measured using the diameter of transparent zone on the fibrin plate based on urokinase (60 000 IU/mg; NICPBP, Beijing, China) standard solutions. The activity of each milligram protein is defined as an enzyme activity unit (IU/mg). With bovine serum albumin used as a criterion, the protein concentration was measured with the bicinchoninic acid protein assay reagent kit (Sigma, Beijing, China).</p></sec><sec id="Sec5"><title>Enzyme purification</title><p id="Par9">The DFE27 enzyme was purified successively at 4&#x02009;&#x000b0;C by UNOsphere Q column chromatography, Sephadex G-75 gel filtration, and high-performance liquid chromatography (HPLC). Firstly, the proteins of 5&#x02009;L medium supernatant were separated by 40&#x02013;70% (NH<sub>4</sub>)<sub>2</sub>SO<sub>4</sub> precipitation, followed by centrifugation at 10,000&#x02009;rpm for 15&#x02009;min to acquire target proteins, dissolution of the protein pellets in 20&#x02009;mM Tris-HCl buffer (pH 8.8) and dialysis against the same buffer overnight. Secondly, the dialyzed enzyme was concentrated and then loaded on a UNOsphere Q anion exchange column, followed by elution at a rate of 1.0&#x02009;ml/min with 20&#x02009;mM Tris-HCl buffer (pH 8.8) containing 1&#x02009;M of NaCl and measuring the enzyme activity and protein concentration separately from the collected elution peaks. Next, the highly active solution was passed through a Sephadex G-75 (Pharmacia, Shanghai, China) column (1.5&#x02009;cm&#x02009;&#x000d7;&#x02009;25&#x02009;cm) previously balanced with 20&#x02009;mM Tris-HCl buffer (pH 7.0) at a flow speed of 0.2&#x02009;ml/min. Meanwhile, the elution peaks were collected separately for measuring the protein concentration and enzyme activity, and the portion with highest enzyme activity was further concentrated and freeze-dried. Lastly, the freeze-dried portion was dissolved with 200&#x02009;mM Na<sub>2</sub>HPO<sub>4</sub> solution, and HPLC analyses were performed with a GF-250 column (9.4&#x02009;mm&#x02009;&#x000d7;&#x02009;250&#x02009;mm) on an Agilent 1200 series instrument by using 200&#x02009;mM Na<sub>2</sub>HPO<sub>4</sub> solution at 1&#x02009;ml/min, 23&#x02009;&#x000b0;C and 280&#x02009;nm. The absorption peaks were collected and the purity of the freeze-dried products was measured.</p></sec><sec id="Sec6"><title>SDS-PAGE</title><p id="Par10">To evaluate the purity and molecular mass of the proteins, SDS-PAGE was done at room temperature on a Modular Mini-Protein II Electrophoresis System (Bio-Rad, Hercules, USA). Specifically, the proteins were electrophoresed in a 5% stacking gel and 12% resolving gel of polyacrylamide, followed by staining with 0.25% Coomassie Blue R-250 (Sigma, Beijing, China).</p></sec><sec id="Sec7"><title>Zymography</title><p id="Par11">To perform fibrin zymography as described in the literature<sup><xref ref-type="bibr" rid="CR28">28</xref></sup>, 0.12% (w/v) fibrinogen and 100&#x02009;&#x003bc;l thrombin (10 IU/ml) were used to prepare a 12% polyacrylamide gel. After electrophoresis at 12&#x02009;mA and 4&#x02009;&#x000b0;C, the gel was incubated for 30&#x02009;min at room temperature in 50&#x02009;mM&#x02009;pH 7.0 Tris-HCl containing 2.5% (v/v) Triton X-100, followed by washing in distilled water for 30&#x02009;min and incubation at 37&#x02009;&#x000b0;C for 12&#x02009;h in the zymogram reaction buffer consisting of 0.02% (w/v) NaN<sub>3</sub> and 30&#x02009;mM&#x02009;pH 7.0 Tris-HCl<sup><xref ref-type="bibr" rid="CR29">29</xref></sup>. Finally, after staining with Coomassie blue R-250 for 2&#x02009;h, the gel was destained, and the non-staining regions of the fibrin gel were defined as the active bands.</p></sec><sec id="Sec8"><title>Effects of pH and temperature on DFE27 activity</title><p id="Par12">To measure the effects of pH on the fibrinolytic activity, the purified enzyme solution was adjusted to the fibrinolytic activity of 50 IU/ml at 37&#x02009;&#x000b0;C and maintained for 30&#x02009;min in the following different buffer solutions (0.1&#x02009;M): HAc-NaAc buffer (pH 4.0, 5.0), Tris-HCl buffer (pH 8.0, 9.0), phosphate buffer (pH 6.0, 7.0), and glycine-NaOH buffer (pH 10.0, 11.0). To measure pH stability, the enzyme was incubated in the buffers separately from pH 5.0 to 10.0 at 37&#x02009;&#x000b0;C for 0, 10, 30, 60 and 90&#x02009;min. After readjusting the pH to 7.5, the residual fibrinolytic activity was determined. The effects of temperature on the fibrinolytic activity were determined by incubating the enzyme at different temperatures for 30&#x02009;min and then measuring the residual activity (purified fibrinolytic enzyme solution in 20&#x02009;mM&#x02009;pH 7.5 Tris-HCl buffer, 50 IU/ml). The thermal stability was investigated by assaying the residual fibrinolytic activity in pH 7.5 Tris-HCl buffer at 37, 45, 50 and 60&#x02009;&#x000b0;C for 0, 30, 60, 90, and 120&#x02009;min.</p></sec><sec id="Sec9"><title>Effect of inhibitors and metal ions on DFE27 activity</title><p id="Par13">The fibrinolytic enzyme type was determined by evaluating the effects of multifarious inhibitors on the fibrinolytic activity. Briefly, the purified enzyme solution (50 IU/ml) was pre-incubated at 37&#x02009;&#x000b0;C for 30&#x02009;min separately with each of the following inhibitors: 5.0&#x02009;mM serine protease inhibitor phenylmethanesulfonyl fluoride (PMSF; Sigma, Beijing, China), 5.0&#x02009;mM metalloprotease inhibitor ethylene diamine tetraacetic acid (EDTA; Sigma, Beijing, China), 10&#x02009;&#x000b5;M aspartic protease inhibitor pepstatin A (Sigma, Beijing, China), 1.0&#x02009;mM cysteine protease inhibitor trans-epoxysuccinyl-L-leucylamido-(4-guanidino) butane (E64; Sigma, Beijing, China), and 1.0&#x02009;mM aminopeptidase inhibitor bestatin (Sigma, Beijing, China). To measure the effects of metal ions on the activity, the fibrinolytic enzyme (50 IU/ml) was pre-incubated separately with different metal ions (final concentration 5&#x02009;mM) at pH 7.5 and 37&#x02009;&#x000b0;C for 30&#x02009;min. The enzyme solution without added ions was used as a control.</p></sec><sec id="Sec10"><title>Substrate specificity of DFE27</title><p id="Par14">The DFE27 specificity was evaluated by using the synthetic substrates of N-succinyl-Ala-Ala-Pro-Phe-p-nitroanilide (<italic>p</italic>NA) (characteristic substrate for subtilisin or chymotrypsin; Sigma, Beijing, China), D-Val-Leu-Lys-<italic>p</italic>NA (characteristic substrate for plasmin; Sigma, Beijing, China), and D-Val-leu-Arg-<italic>p</italic>NA (characteristic substrate for kallilrein; Sigma, Beijing, China). The reaction mixture contained 8&#x02009;&#x003bc;l of 1&#x02009;mM synthetic substrate, 10&#x02009;&#x003bc;l of enzyme solution and 20&#x02009;&#x003bc;l of 100&#x02009;mM&#x02009;pH 7.0 Tris-HCl buffer. After incubating the mixture at 37&#x02009;&#x000b0;C for 30&#x02009;min, the absorbance of released <italic>p</italic>NA at 405&#x02009;nm was measured with a spectrophotometer to determine the amidolytic activity.</p></sec><sec id="Sec11"><title>PCR, sequencing and sequence analysis</title><p id="Par15">DNA fragment was PCR amplified with the TIANamp Bacteria DNA Kit (Tiangen, Shanghai, China) using the primers 5&#x02032;-CTGAATCAGGGAAATCAAACGG-3&#x02032; and 5&#x02032;-GTCGTTACTGAGCTGCCGCCTGTAC-3&#x02032; for forward and reverse reactions<sup><xref ref-type="bibr" rid="CR30">30</xref></sup>, respectively. The 50&#x02009;&#x000b5;l of reaction mixture consisted of 5&#x02009;&#x000b5;l of 10x&#x000a0;PCR buffer, 0.5&#x02009;&#x000b5;l of Taq polymerase, 1&#x02009;&#x000b5;l of genomic DNA, 4&#x02009;&#x000b5;l of 2.5&#x02009;mM dNTP, 37.5&#x02009;&#x000b5;l of ddH<sub>2</sub>O and 1&#x02009;&#x000b5;l of each of primers. The PCR was performed under the conditions of 1 cycle at 94&#x02009;&#x000b0;C for 3&#x02009;min, 30 cycles (at 94&#x02009;&#x000b0;C and 55&#x02009;&#x000b0;C for 1&#x02009;min and 72&#x02009;&#x000b0;C for 2.5&#x02009;min), and a final cycle at 72&#x02009;&#x000b0;C for 10&#x02009;min. After purifying and sequencing the PCR product, the nucleotide acid sequence of this enzyme was converted into amino acid sequence at the website <ext-link ext-link-type="uri" xlink:href="http://web.expasy.org/translate/">http://web.expasy.org/translate/</ext-link>. Multiple sequence alignments of DFE27 and other enzymes were performed using GeneDoc software.</p></sec><sec id="Sec12"><title>Statistical analysis</title><p id="Par16">All the data were presented as the mean&#x02009;&#x000b1;&#x02009;SD and subjected to analysis of variance and <italic>F</italic> test using SPSS 11.0 statistical software (SPSS, Inc. Chicago, IL, USA).</p></sec></sec><sec id="Sec13" sec-type="results"><title>Results</title><sec id="Sec14"><title>Strain isolation and identification</title><p id="Par17">A total of 156 strains showing fibrinolytic activity were isolated from 7 samples, and the isolate DC27 with the strongest fibrin-degrading activity was chosen for further study. The results showed that the strain DC27 was Gram positive, rod shaped and endospore forming (more details are shown in Supplemental Table&#x000a0;<xref rid="MOESM1" ref-type="media">S1</xref>), with a typical characteristic of <italic>B</italic>. <italic>subtilis</italic>. The 16&#x02009;S rDNA sequence obtained from it (1461&#x02009;bp; NCBI no. MK779713) had 99% sequence similarity to that of <italic>B</italic>. <italic>subtilis</italic> DSM 10 (NCBI no. NR_027552.1). The strain was identified as <italic>B</italic>. <italic>subtilis</italic> and designated as <italic>B</italic>. <italic>subtilis</italic> DC27 which was deposited at the China Center for Type Culture Collection (CCTCC, M2015573).</p></sec><sec id="Sec15"><title>Optimization of fermentation conditions</title><p id="Par18">In order to obtain more enzymes, the medium components and culture conditions were optimized. Results showed that soluble corn starch and soybean peptone were the optimal carbon and nitrogen sources, respectively (Supplemental Table&#x000a0;<xref rid="MOESM1" ref-type="media">S2</xref>). The optimal conditions consisted of medium volume 40&#x02009;ml/250&#x02009;ml, inoculum size 2%, initial pH 8.0, and incubation temperature 32&#x02009;&#x000b0;C (Supplemental Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">S1</xref>).</p></sec><sec id="Sec16"><title>Purification of DFE27</title><p id="Par19">The chromatograms are shown in Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>, and the protease yield and purity in each purification step are presented in Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>. In Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1a</xref>, proteins in peak A and B exhibited fibrinolytic activities, with the highest fibrinolytic activity in peak A, thus proteins in peak A were collected and purified by Sephadex G-75. The elution of a sephadex G-75 column resulted in a major single elution peak based on the protein size (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1b</xref>). The freeze-dried fraction from 65&#x02009;&#x000b1;&#x02009;2&#x02009;min of elution time in sephadex G-75 gel filtration was further purified by HPLC (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1c</xref>), and a sharp single peak occurred at around 10.978&#x02009;min. After purification by UNOsphere Q, Sephadex G-75 and HPLC, DFE27 was 69.1-fold purified with a yield of 12.73% relative to that of the crude enzyme (Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>). The specific activity was estimated to be 11274.4 IU/mg (urokinase activity units/mg of protein) for the ultimate enzyme.<fig id="Fig1"><label>Figure 1</label><caption><p>The purification of DFE27 by chromatography. (<bold>a</bold>) Purification of DFE27 using UNOsphere Q anion-exchange column for stepwise gradient elution with 20&#x02009;mM Tris-HCl buffer (pH 8.8) containing 1&#x02009;M of NaCl at a flow rate of 1.0&#x02009;ml/min and 4&#x02009;&#x000b0;C; (<bold>b</bold>) Further purification of DFE27 by Sephadex G-75 column chromatography eluted with 20&#x02009;mM Tris-HCl buffer (pH 7.0) at a flow rate of 0.2&#x02009;ml/min and 4&#x02009;&#x000b0;C; (<bold>c</bold>) HPLC purification of DFE27 using 200&#x02009;mM Na<sub>2</sub>HPO<sub>4</sub> solution as mobile phase at a flow rate of 1&#x02009;ml/min, a column temperature of 23&#x02009;&#x000b0;C and a detection wavelength of 278&#x02009;nm.</p></caption><graphic xlink:href="41598_2019_45686_Fig1_HTML" id="d29e687"/></fig><table-wrap id="Tab1"><label>Table 1</label><caption><p>Purification of DFE27 from <italic>B</italic>.<italic>subtilis</italic> DC27.</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Purification step</th><th>Total protein (mg)</th><th>Total activity (IU)</th><th>Specific activity (IU/mg)</th><th>Yield (%)</th><th>Purification fold</th></tr></thead><tbody><tr><td>Medium supernatant</td><td>6929.82</td><td>1130098</td><td>163.1</td><td>100</td><td>1</td></tr><tr><td>(NH<sub>4</sub>)<sub>2</sub>SO<sub>4</sub></td><td>1387.10</td><td>675288</td><td>486.8</td><td>59.75</td><td>3.0</td></tr><tr><td>UNOsphere Q</td><td>61.42</td><td>361287</td><td>5882.2</td><td>31.97</td><td>36.1</td></tr><tr><td>Sepharose G-75</td><td>15.56</td><td>167493</td><td>10764.3</td><td>14.82</td><td>66.0</td></tr><tr><td>HPLC</td><td>12.76</td><td>143861</td><td>11274.4</td><td>12.73</td><td>69.1</td></tr></tbody></table></table-wrap></p></sec><sec id="Sec17"><title>Molecular mass of DFE27</title><p id="Par20">The molecular mass (Mr) of purified DFE27 was determined to be 29&#x02009;kDa by SDS-PAGE (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>). The clear band indicated that the protein was purified to homogeneity by HPLC and it contained a single subunit or several subunits with the identical Mr of 29&#x02009;kDa (Lane 1). The enzyme assay also revealed that the purified DFE27 had a molecular mass of about 29&#x02009;kDa, with a very clear hydrolyzed band of approximately 29&#x02009;kDa detected on the fibrin zymography (Lane 2).<fig id="Fig2"><label>Figure 2</label><caption><p>The purity and molecular mass of the purified DFE27 enzyme as determined by SDS-PAGE and fibrin zymography. M, molecular mass standards; 1, The purified DFE27; 2, Fibrin zymography of the purified DFE27.</p></caption><graphic xlink:href="41598_2019_45686_Fig2_HTML" id="d29e851"/></fig></p></sec><sec id="Sec18"><title>Optimum pH, temperature and stability of DFE27</title><p id="Par21">The DFE27 showed the highest activity at pH 7.0 (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3a</xref>), and was relatively stable at pH 6.0 to 10.0 and 37&#x02009;&#x000b0;C for 90&#x02009;min, but the enzyme stability abruptly decreased at pH 5.0 (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3b</xref>). Moreover, DFE27 showed the highest activity at 45&#x02009;&#x000b0;C (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3c</xref>). The purified enzyme remained stable from 37&#x02009;&#x000b0;C to 50&#x02009;&#x000b0;C, unstable at a temperature above 60&#x02009;&#x000b0;C, and exhibited almost no activity after treatment at 60&#x02009;&#x000b0;C and 70&#x02009;&#x000b0;C for 30&#x02009;min (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3d</xref>).<fig id="Fig3"><label>Figure 3</label><caption><p>Effects of pH and temperature on fibrinolytic activity and stability of DFE27. (<bold>a</bold>) Optimal pH value was obtained by incubating the DFE27 enzyme in buffer solutions with a different pH value at 37&#x02009;&#x000b0;C for 30&#x02009;min to determine the fibrinolytic activity; (<bold>b</bold>) pH stability was determined by incubating the enzyme in different buffers at pH 5.0 to 10.0 and measuring the residual fibrinolytic activity at 37&#x02009;&#x000b0;C after adjusting to pH 7.5; (<bold>c</bold>) Optimal temperature was determined by incubating the enzyme at different temperatures at pH 7.5 for 30&#x02009;min to determine the activity; (<bold>d</bold>) Thermostability was determined by incubating the enzyme in pH 7.5 Tris-HCl buffer at 37, 45, 50 and 60&#x02009;&#x000b0;C for 0, 30, 60, 90, and 120&#x02009;min and measuring the residual fibrinolytic activity. Values are means&#x02009;&#x000b1;&#x02009;SD from three independent experiments.</p></caption><graphic xlink:href="41598_2019_45686_Fig3_HTML" id="d29e891"/></fig></p></sec><sec id="Sec19"><title>Effects of inhibitors and metal ions on DFE27 activity</title><p id="Par22">The effects of a number of known protease inhibitors and 7 metal ions on DFE27 activity are presented in Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>. DFE27 was completely inhibited by PMSF, suggesting it is a serine protease. However, the enzyme activity was increased by 122.02% and 121.75% by Ca<sup>2+</sup>, and K<sup>+</sup>, respectively. Furthermore, the enzyme activity was slightly influenced by Mn<sup>2+</sup>, Zn<sup>2+</sup> and Mg<sup>2+</sup>, but significantly inhibited by Cu<sup>2+</sup> and Fe<sup>2+</sup> with a decrease of more than 81.78% and 39.07% respectively when compared with the control.<table-wrap id="Tab2"><label>Table 2</label><caption><p>Effects of protease inhibitors and metal ions on DFE27 activity.</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Inhibitor/metal ion</th><th>Concentration</th><th>Relative activity (%)</th></tr></thead><tbody><tr><td>None</td><td>&#x02014;</td><td>100.00&#x02009;&#x000b1;&#x02009;0.26</td></tr><tr><td>PMSF</td><td>5&#x02009;mM</td><td>0.00&#x02009;&#x000b1;&#x02009;0.00</td></tr><tr><td>EDTA</td><td>5&#x02009;mM</td><td>85.99&#x02009;&#x000b1;&#x02009;2.11</td></tr><tr><td>Pepstatin A</td><td>10&#x02009;&#x000b5;M</td><td>88.91&#x02009;&#x000b1;&#x02009;1.38</td></tr><tr><td>E64</td><td>1&#x02009;mM</td><td>94.65&#x02009;&#x000b1;&#x02009;0.90</td></tr><tr><td>Bestatin</td><td>1&#x02009;mM</td><td>91.97&#x02009;&#x000b1;&#x02009;0.00</td></tr><tr><td>Mn<sup>2+</sup></td><td>5&#x02009;mM</td><td>104.79&#x02009;&#x000b1;&#x02009;0.30</td></tr><tr><td>Zn<sup>2+</sup></td><td>5&#x02009;mM</td><td>97.93&#x02009;&#x000b1;&#x02009;9.06</td></tr><tr><td>Cu<sup>2+</sup></td><td>5&#x02009;mM</td><td>18.22&#x02009;&#x000b1;&#x02009;0.91</td></tr><tr><td>Ca<sup>2+</sup></td><td>5&#x02009;mM</td><td>122.02&#x02009;&#x000b1;&#x02009;5.71</td></tr><tr><td>Fe<sup>2+</sup></td><td>5&#x02009;mM</td><td>61.93&#x02009;&#x000b1;&#x02009;4.28</td></tr><tr><td>K<sup>+</sup></td><td>5&#x02009;mM</td><td>121.75&#x02009;&#x000b1;&#x02009;1.43</td></tr><tr><td>Mg<sup>2+</sup></td><td>5&#x02009;mM</td><td>90.00&#x02009;&#x000b1;&#x02009;0.43</td></tr></tbody></table></table-wrap></p></sec><sec id="Sec20"><title>Amidolytic activity of DFE27</title><p id="Par23">Several synthetic substrates were used to evaluate the amidolytic activity of the purified DFE27 (Table&#x000a0;<xref rid="Tab3" ref-type="table">3</xref>). D-Val-Leu-Lys-<italic>p</italic>NA (for plasmin) was the most sensitive substrate for DFE27, with lesser effects from N-Suc-Ala-Ala-Pro-Phe-<italic>p</italic>NA (for chymotrypsin or subtilisin) and D-Val-Leu-Arg-<italic>p</italic>NA (kallikrein).<table-wrap id="Tab3"><label>Table 3</label><caption><p>Synthetic substrate specificity of DFE27.</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Synthetic substrate (1&#x02009;mM)</th><th>Substrate hydrolysis (mmol&#x000b7;min<sup>&#x02212;1</sup>&#x000b7;ml<sup>&#x02212;1</sup>)</th><th>Target enzymes</th></tr></thead><tbody><tr><td>N-Suc-Ala-Ala-Pro-Phe-<italic>p</italic>NA</td><td>12.527</td><td>Subtilisin or chymotrypsin</td></tr><tr><td>D-Val-Leu-Lys-<italic>p</italic>NA</td><td>225.291</td><td>Plasmin, plasminogen</td></tr><tr><td>D-Val-Leu-Arg-<italic>p</italic>NA</td><td>47.656</td><td>Kallikrein</td></tr></tbody></table></table-wrap></p></sec><sec id="Sec21"><title>Fibrinolytic action mode of DFE27</title><p id="Par24">Fibrin plate, without heat treatment, was viewed as rich in plasminogen, because commercially purchased fibrinogen usually contains only a small amount of plasminogen, while the fibrin plate, with a 30&#x02009;min heat treatment at 80&#x02009;&#x000b0;C to inactivate plasminogen, is defined as free from plasminogen. As shown in Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>, clear hydrolyzed zones were formed in both the plasminogen-free and -rich plates. The fibrinolytic activity of DFE27 in the plasminogen-free plate was approximately 90% of the activity in the plasminogen-rich plate (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>), indicating that the purified DFE27 can not only directly hydrolyze fibrin, but also convert plasminogen to plasmin.<fig id="Fig4"><label>Figure 4</label><caption><p>The fibrinolytic action mode. The fibrinolytic activity of DFE27 was detected on the plasminogen-rich and -free plates. The fibrin plate without heat treatment was considered as plasminogen-rich plate, and the fibrin plate with the 80&#x02009;&#x000b0;C heat treatment for 30&#x02009;min to inactivate plasminogen was defined as plasminogen-free plate.</p></caption><graphic xlink:href="41598_2019_45686_Fig4_HTML" id="d29e1201"/></fig></p></sec><sec id="Sec22"><title>Amino acid sequence alignment of DFE27 with other serine proteases</title><p id="Par25">Multiple sequence alignment of DFE27 and other serine proteases was performed and the results are shown in Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5</xref>. Sequence analysis and alignment results showed that DFE27 had high similarity to subtilisin BPN&#x02019; (K02496.1) with 98% identity, and the partial sequence showed 86%, 85%, 67% identity to that of NAT (S51909.1), E (K01988.1) and Carls (X03341.1), respectively. At the N-terminus of the enzyme, the initial 24 amino acid residues were found to be AQSVPYGVSQIKAPALHSQGFTGS, which was different from that of BPN&#x02019;, NAT, E and Carls.<fig id="Fig5"><label>Figure 5</label><caption><p>Multiple sequence alignment of DFE27 and other serine proteases. DFE27 from <italic>B</italic>. <italic>subtilis</italic> DC27, present study; BPN&#x02019; from <italic>B</italic>. <italic>amyloliquefaciens</italic>, K02496.1; NAT from <italic>B</italic>. <italic>subtilis</italic>, S51909.1; E from <italic>B</italic>. <italic>subtilis</italic>, K01988.1; Carls from <italic>B</italic>. <italic>licheniformis</italic>, X03341.1. The closed rectangle shows the N-terminal sequence of the first 24 amino acids.</p></caption><graphic xlink:href="41598_2019_45686_Fig5_HTML" id="d29e1251"/></fig></p></sec><sec id="Sec23"><title>Comparison of DFE27 with other fibrinolytic enzymes</title><p id="Par26">Comparative analysis of DFE27 with other fibrinolytic enzymes was shown in Table&#x000a0;<xref rid="Tab4" ref-type="table">4</xref>, revealed that DFE27 displayed unique substrate specificity and fibrinolytic action mode, which are different from other fibrinolytic enzymes originated from fermented foods. It is obvious that the sequence of DFE27 and DFE showed high homology, but the originated microorganism, fibrinolytic action mode and substrate specificity are extremely different. Furthermore, the initial 24-amino-acid residues were different from that of BsfA<sup><xref ref-type="bibr" rid="CR28">28</xref></sup>, subtilisin QK-2<sup><xref ref-type="bibr" rid="CR29">29</xref></sup> and subtilisin NAT (NK)<sup><xref ref-type="bibr" rid="CR30">30</xref></sup>, and the amino acid sequence of DFE27 showed only 85%, 84%, 86% similarity with BsfA, QK-2 and NAT, which are from fermented foods, respectively.<table-wrap id="Tab4"><label>Table 4</label><caption><p>Comparison of DFE27 and other fibrinolytic enzymes.</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Fibrinolytic enzyme</th><th>Source</th><th>Microorganism</th><th>Molecular weight (kDa)</th><th>Substrate specificity</th><th>Fibrinolytic action mode</th><th>Amino acid similarity (%)</th><th>NCBI Sequence No.</th><th>Reference</th></tr></thead><tbody><tr><td>DFE27</td><td>
<italic>Douchi</italic>
</td><td><italic>B</italic>. <italic>subtilis</italic> DC27</td><td>29</td><td>D-Val-Leu-Lys-pNA</td><td>Direct and indirect</td><td>100</td><td>MG860912.1</td><td>Present study</td></tr><tr><td>Subtilisin DFE</td><td>
<italic>Douchi</italic>
</td><td><italic>B</italic>. <italic>amyloliquefacien</italic>s DC-4</td><td>28</td><td>Suc-Ala-Ala-Pro-Phe-pNA</td><td>Direct</td><td>99</td><td>AAZ66858.1</td><td>Peng <italic>et al</italic>. 2003</td></tr><tr><td>BsfA</td><td>
<italic>Kimchi</italic>
</td><td><italic>B</italic>. <italic>subtilis</italic> ZA400</td><td>28.4</td><td>ND</td><td>ND</td><td>85</td><td>JN392072.1</td><td>Ahn <italic>et al</italic>. 2015</td></tr><tr><td>Subtilisin QK-2</td><td>Fermented soybean</td><td><italic>B</italic>. <italic>subtilis</italic> QK02</td><td>28</td><td>Suc-Ala-Ala-Pro-Phe-pNA</td><td>Direct</td><td>84</td><td>AMM02745.1</td><td>Ko <italic>et al</italic>. 2004</td></tr><tr><td>NAT</td><td>
<italic>Natto</italic>
</td><td><italic>B</italic>. <italic>subtilis</italic> (<italic>natto</italic>)</td><td>30</td><td>Suc-Ala-Ala-Pro-Phe-pNA</td><td>Direct</td><td>86</td><td>S51909.1</td><td>Nakamura <italic>et al</italic>. 1992</td></tr></tbody></table><table-wrap-foot><p>ND, the result was not determined.</p></table-wrap-foot></table-wrap></p></sec></sec><sec id="Sec24" sec-type="discussion"><title>Discussion</title><p id="Par27">Thrombolytic therapies with plasminogen activators (t-PA, SK and UK) have high potential in treating thrombosis, facilitating the use of plasminogen activators in medicine today, but their high prices and side effects limit their wide application. Microbial fibrinolytic enzymes, isolated from food-grade microorganisms, are more in demand than typical thrombolytic agents. Nattokinase (NK) isolated from <italic>natto</italic> in 1987 is one of the most important discoveries in fibrinolytic enzymes, and a daily oral administration of as low as 50&#x02009;g of <italic>natto</italic> or 2,000 fibrin units may help prevent the conditions leading to thrombosis<sup><xref ref-type="bibr" rid="CR31">31</xref></sup>. Moreover, NK can maintain its activity for 2&#x02013;12&#x02009;h, whereas a fibrinolytic injection can only retain its efficiency for 4&#x02013;20&#x02009;min. Currently, NK is often employed as a fibrinolytic enzyme in hospitals<sup><xref ref-type="bibr" rid="CR32">32</xref></sup>. Japan has the highest life expectancy around the globe, probably partially due to the increased use of fermented soybean food <italic>natto</italic><sup><xref ref-type="bibr" rid="CR2">2</xref></sup>.</p><p id="Par28"><italic>Douchi</italic>, another fermented soybean food in China, is as ancient as <italic>natto</italic> and was also found to contain fibrinolytic enzymes formed by the bacteria harbored in it. In view of their impressive thrombolytic efficacy and safety, these microbial fibrinolytic enzymes may be excellent candidates for thrombolytic therapies. In this study, a highly potential 29&#x02009;kDa fibrinolytic protease &#x02018;DFE27&#x02019;, as estimated by both SDS-PAGE and fibrin zymography, was identified from <italic>B</italic>. <italic>subtillis</italic> isolated from <italic>Douchi</italic>. Most fibrinolytic enzymes from food have a molecular mass between 28 and 30&#x02009;kDa, and the molecular mass of DFE27 (29&#x02009;kDa) was similar to that of Subtilisin DFE (28&#x02009;kDa)<sup><xref ref-type="bibr" rid="CR18">18</xref></sup>, BsfA (28.4&#x02009;kDa)<sup><xref ref-type="bibr" rid="CR33">33</xref></sup>, Subtilisin QK-2 (28&#x02009;kDa)<sup><xref ref-type="bibr" rid="CR34">34</xref></sup> and NAT(30&#x02009;kDa)<sup><xref ref-type="bibr" rid="CR35">35</xref></sup>. Furthermore, the activity of DFE27 was obviously inhibited by PMSF, proving that it is a serine protease. To date, most known fibrinolytic enzymes such as nattokinase and DFE are serine proteases<sup><xref ref-type="bibr" rid="CR18">18</xref>,<xref ref-type="bibr" rid="CR31">31</xref></sup>.</p><p id="Par29">The results from chromogenic substrates showed that DFE27 can perform the function of t-PA in hydrolyzing the synthetic substrate D-Val-Leu-Lys-<italic>p</italic>NA for plasmin, suggesting that DFE27 is a serine protease similar to plasmin and can degrade plasminogen in vivo as a potential fibrinolytic agent. Similar characteristics were found in serine proteases which are isolated from <italic>Pleurotus eryngii</italic>, <italic>Periserrula leucophryna</italic>, <italic>Porcellio scaber</italic> Latreille, <italic>Cordyceps militaris</italic> and <italic>Asterina pectinifera</italic>, respectively<sup><xref ref-type="bibr" rid="CR36">36</xref>&#x02013;<xref ref-type="bibr" rid="CR40">40</xref></sup>. The optimum substrate of DFE27 is also similar to that of fibrinolytic enzymes obtained from fermented foods, such as <italic>Natto</italic> and Chungkook-jang<sup><xref ref-type="bibr" rid="CR31">31</xref>,<xref ref-type="bibr" rid="CR41">41</xref></sup>, but different from that of fibrinolytic enzymes of <italic>Douchi</italic><sup><xref ref-type="bibr" rid="CR4">4</xref>,<xref ref-type="bibr" rid="CR18">18</xref></sup>.</p><p id="Par30">DFE27 could also hydrolyze the fibrin independently as indicated by a clear band of 29&#x02009;kDa on fibrin zymogram as well as its high fibrinolytic activity on both plasminogen-rich and -free plates, demonstrating its strong plasmin-like activity to lyse fibrin and fibrinogen. Interestingly, DFE27 was found to have the ability to activate plasminogen into plasmin, as evidenced by its performance in stimulating fibrinolytic activity on the plasminogen-rich fibrin plate and cleaving fibrin and fibrinogen as a direct acting fibrinolytic agent. This effect is in good agreement with that of fibrinolytic enzymes from <italic>Pleurotus eryngii</italic><sup><xref ref-type="bibr" rid="CR36">36</xref></sup>, <italic>Paecilomyces tenuipes</italic><sup><xref ref-type="bibr" rid="CR42">42</xref></sup>, <italic>Streptomyces</italic> sp.CS684<sup><xref ref-type="bibr" rid="CR43">43</xref></sup>, and <italic>Asterina pectinifera</italic><sup><xref ref-type="bibr" rid="CR40">40</xref></sup>. Collectively, the bifunctional DFE27 enzyme is obviously superior to all the other known fibrinolytic enzymes in thrombolysis.</p><p id="Par31">It is worth noting that the enzyme activity reached 5145.53&#x02009;&#x000b1;&#x02009;52.00 IU/ml using a 50&#x02009;L fermenter under the optimal culture conditions (data not shown). This is probably the highest yield level of <italic>Douchi</italic> fibrinolytic enzyme in the strains reported in the literature so far. Recently, statistical methods such as response surface methodology and central composite design have been effectively and frequently used to optimize the process parameters for enhancing the enzyme production<sup><xref ref-type="bibr" rid="CR44">44</xref>&#x02013;<xref ref-type="bibr" rid="CR46">46</xref></sup>. Meanwhile, several genetically engineered strains, such as <italic>B</italic>. <italic>subtilis</italic>, <italic>Escherichia coli</italic>, and <italic>Pichia</italic>, are constructed for high production of enzyme. Therefore, <italic>B</italic>. <italic>subtilis</italic> DC27 has great application prospect for industrial production and further research due to its excellent characteristics for high yield.</p><p id="Par32">DFE27 was classified as a serine protease based on its activity toward protease inhibitors and shared high similarity with subtilisin DFE (99%) and subtilisin BPN&#x02019;(97.5%), two serine proteases originated from <italic>B</italic>. <italic>amyloliquefaciens</italic>. However, DFE27 showed significant differences from them in terms of strain source, optimum substrate specificity, fibrinolytic action mode or N-terminal sequence. For example, the N-terminal 24-amino-acids sequence of DFE27 was different from that of other fibrinolytic enzymes originated from other Asian fermented foods, such as <italic>natto</italic><sup><xref ref-type="bibr" rid="CR31">31</xref>,<xref ref-type="bibr" rid="CR35">35</xref></sup>, fermented soybean<sup><xref ref-type="bibr" rid="CR34">34</xref></sup>, doen-jang<sup><xref ref-type="bibr" rid="CR28">28</xref></sup>, Chungkook-jang<sup><xref ref-type="bibr" rid="CR41">41</xref></sup> and kimchi<sup><xref ref-type="bibr" rid="CR33">33</xref></sup>. In addition, even though showing identical action mode, the DFE27 exhibited different N-terminal sequence or substrate hydrolysis characteristic with other <italic>Bacillus</italic> fibrinolytic enzyme originated from <italic>Douchi</italic>, such as fibrinolytic enzyme FS33 and another enzyme from <italic>Bacillus</italic> sp. nov. SK006 screened from <italic>shrimp paste</italic><sup><xref ref-type="bibr" rid="CR4">4</xref>,<xref ref-type="bibr" rid="CR47">47</xref></sup>.</p><p id="Par33">DFE27 showed only 85.6% similarity with NAT which originates from traditional Japanese food natto and exhibited strong fibrinolytic enzyme activity. Furthermore, the DFE27 can both directly degrade fibrin and hydrolyze fibrin through activating plasminogen into plasmin. These unique characteristics and the sequence difference demonstrate that it is a novel fibrinolytic enzyme from <italic>Douchi</italic> and has wide potential applications in food or medicine for the treatment and prevention of thrombosis. Further studies should focus on the thrombolytic effects of DFE27 <italic>in vitro</italic> and <italic>in vivo</italic> and optimization of its dose in drugs or food additives.</p></sec><sec sec-type="supplementary-material"><title>Supplementary information</title><sec id="Sec25"><p>
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="41598_2019_45686_MOESM1_ESM.doc"><caption><p>Supplementary information</p></caption></media></supplementary-material>
</p></sec></sec></body><back><fn-group><fn><p><bold>Publisher&#x02019;s note:</bold> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn><fn><p>Yuanliang Hu and Dan Yu contributed equally.</p></fn></fn-group><sec><title>Supplementary information</title><p><bold>Supplementary information</bold> accompanies this paper at 10.1038/s41598-019-45686-y.</p></sec><ack><title>Acknowledgements</title><p>This work got the financial support of the Grant 31300042 of Natural Science Foundation of China, Grant AMLKF201708 of the State Key Laboratory of Agricultural Microbiology, and Grant EWPL201707 of Hubei Key Laboratory of Edible Wild Plants Conservation and Utilization.</p></ack><notes notes-type="author-contribution"><title>Author Contributions</title><p>Y.D. and W.Z.T. designed experiments, performed experiments and analyzed data. H.Y.M. and H.Y.L. wrote the manuscript. Y.D, H.J.J. and R.T. checked and revised the manuscript. L.Y.X. and H.Y.M. are the guarantors of this work. All authors have proofread the manuscript critically and approved the final manuscript.</p></notes><notes notes-type="data-availability"><title>Data Availability</title><p>The authors declared all data are available.</p></notes><notes notes-type="COI-statement"><title>Competing Interests</title><p id="Par34">The authors declare no competing interests.</p></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koene</surname><given-names>RJ</given-names></name><etal/></person-group><article-title>Shared risk factors in cardiovascular disease and cancer</article-title><source>Circulation.</source><year>2016</year><volume>133</volume><fpage>1104</fpage><lpage>1114</lpage><pub-id pub-id-type="doi">10.1161/circulationaha.115.020406</pub-id><?supplied-pmid 26976915?><pub-id pub-id-type="pmid">26976915</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kotb</surname><given-names>E</given-names></name></person-group><article-title>Activity assessment of microbial fibrinolytic enzymes</article-title><source>Appl Microbio Biot.</source><year>2013</year><volume>97</volume><fpage>6647</fpage><lpage>6665</lpage><pub-id pub-id-type="doi">10.1007/s00253-013-5052-1</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Townsend</surname><given-names>N</given-names></name><etal/></person-group><article-title>Cardiovascular disease in Europe-epidemiological update 2015</article-title><source>Eur Heart.</source><year>2015</year><volume>36</volume><fpage>2696</fpage><lpage>2705</lpage><pub-id pub-id-type="doi">10.1093/eurheartj/ehv428</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>CT</given-names></name><etal/></person-group><article-title>Purification and characterization of a fibrinolytic enzyme of <italic>Bacillus subtilis</italic> DC33, isolated from Chinese traditional <italic>Douchi</italic></article-title><source>J Ind Microbiol Biot.</source><year>2006</year><volume>33</volume><fpage>750</fpage><lpage>758</lpage><pub-id pub-id-type="doi">10.1007/s10295-006-0111-6</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yuan</surname><given-names>J</given-names></name><etal/></person-group><article-title>Thrombolytic effects of <italic>Douchi</italic> fibrinolytic enzyme from <italic>Bacillus subtilis</italic> LD-8547 <italic>in vitro</italic> and in vivo</article-title><source>Bmc Biotechnol.</source><year>2012</year><volume>12</volume><fpage>36</fpage><pub-id pub-id-type="doi">10.1186/1472-6750-12-36</pub-id><?supplied-pmid 22748219?><pub-id pub-id-type="pmid">22748219</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Collen</surname><given-names>D</given-names></name><etal/></person-group><article-title>Lijnen, Tissue-type plasminogen activator: a historical perspective and personal account</article-title><source>J Thromb Haemost.</source><year>2004</year><volume>2</volume><fpage>541</fpage><lpage>546</lpage><pub-id pub-id-type="doi">10.1111/j.1538-7933.2004.00645.x</pub-id><?supplied-pmid 15102005?><pub-id pub-id-type="pmid">15102005</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mine</surname><given-names>Y</given-names></name><name><surname>Wong</surname><given-names>AHK</given-names></name><name><surname>Jiang</surname><given-names>B</given-names></name></person-group><article-title>Fibrinolytic enzymes in Asian traditional fermented foods</article-title><source>Food Res Int.</source><year>2005</year><volume>38</volume><fpage>243</fpage><lpage>250</lpage><pub-id pub-id-type="doi">10.1016/j.foodres.2004.04.008</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kotb</surname><given-names>E</given-names></name></person-group><article-title>The biotechnological potential of fibrinolytic enzymes in the dissolution of endogenous blood thrombi</article-title><source>Biotechnol Progr.</source><year>2014</year><volume>30</volume><fpage>656</fpage><lpage>672</lpage><pub-id pub-id-type="doi">10.1002/btpr.1918</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duffy</surname><given-names>MJ</given-names></name></person-group><article-title>Urokinase plasminogen activator and its inhibitor, PAI-1, as prognostic markers in breast cancer: from pilot to level I evidence studies</article-title><source>Clin Chem.</source><year>2002</year><volume>48</volume><fpage>1194</fpage><lpage>1197</lpage><?supplied-pmid 12142372?><pub-id pub-id-type="pmid">12142372</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moukhametova</surname><given-names>LI</given-names></name><etal/></person-group><article-title>Properties of the urokinase-type plasminogen activator modified with phenylglyoxal</article-title><source>Russ Bioorg Chem.</source><year>2002</year><volume>28</volume><fpage>278</fpage><lpage>283</lpage><pub-id pub-id-type="doi">10.1023/a:1019535606678</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wei</surname><given-names>X</given-names></name><etal/></person-group><article-title>Production of fibrinolytic enzyme from <italic>Bacillus amyloliquefaciens</italic> by fermentation of chickpeas, with the evaluation of the anticoagulant and antioxidant properties of chickpeas</article-title><source>J Agr Food Chem.</source><year>2011</year><volume>59</volume><fpage>3957</fpage><lpage>3963</lpage><pub-id pub-id-type="doi">10.1021/jf1049535</pub-id><pub-id pub-id-type="pmid">21391672</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>SB</given-names></name><etal/></person-group><article-title>Purification and characterization of a fibrinolytic subtilisin-like protease of <italic>Bacillus subtilis</italic> TP-6 from an Indonesian fermented soybean</article-title><source>Tempeh. J Ind Microbio Biotech.</source><year>2006</year><volume>33</volume><fpage>436</fpage><lpage>444</lpage><pub-id pub-id-type="doi">10.1007/s10295-006-0085-4</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yao</surname><given-names>Z</given-names></name><etal/></person-group><article-title>Properties of a fibrinolytic enzyme secreted by <italic>Bacillus amyloliquefaciens</italic> RSB34, isolated from <italic>Doenjang</italic></article-title><source>J Microbio Biotech.</source><year>2017</year><volume>27</volume><fpage>9</fpage><lpage>18</lpage><pub-id pub-id-type="doi">10.4014/jmb.1608.08034</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kotb</surname><given-names>E</given-names></name></person-group><article-title>Purification and partial characterization of serine fibrinolytic enzyme from <italic>Bacillus megaterium</italic> KSK-07 isolated from <italic>Kishk</italic>, a traditional egyptian fermented food</article-title><source>Appl Biochem Micro.</source><year>2015</year><volume>51</volume><fpage>34</fpage><lpage>43</lpage><pub-id pub-id-type="doi">10.1134/s000368381501007x</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suzuki</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Dietary supplementation with fermented soybeans suppresses intimal thickening</article-title><source>Nutrition.</source><year>2003</year><volume>19</volume><fpage>261</fpage><lpage>264</lpage><pub-id pub-id-type="doi">10.1016/s0899-9007(02)00853-5</pub-id><?supplied-pmid 12620531?><pub-id pub-id-type="pmid">12620531</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wong</surname><given-names>AHK</given-names></name><etal/></person-group><article-title>Novel fibrinolytic enzyme in fermented shrimp paste, a traditional Asian fermented seasoning</article-title><source>J Agr Food Chem.</source><year>2004</year><volume>52</volume><fpage>980</fpage><lpage>986</lpage><pub-id pub-id-type="doi">10.1021/jf034535y</pub-id><pub-id pub-id-type="pmid">14969560</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>CT</given-names></name><etal/></person-group><article-title>Purification and biochemical properties of a fibrinolytic enzyme from <italic>Bacillus subtilis-</italic>fermented red bean</article-title><source>Food Chem.</source><year>2012</year><volume>133</volume><fpage>1611</fpage><lpage>1617</lpage><pub-id pub-id-type="doi">10.1016/j.foodchem.2012.02.061</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peng</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Purification and characterization of a fibrinolytic enzyme produced by <italic>Bacillus amyloliquefaciens</italic> DC-4 screened from <italic>Douchi</italic>, a traditional Chinese soybean food</article-title><source>Comp Biochem Phys B.</source><year>2003</year><volume>134</volume><fpage>45</fpage><lpage>52</lpage><pub-id pub-id-type="doi">10.1016/s1096-4959(02)00183-5</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>RH</given-names></name><etal/></person-group><article-title>Gene expression and characteristics of a novel fibrinolytic enzyme (subtilisin DFE) in <italic>Escherichia coli</italic></article-title><source>Lett Appl Microbiol.</source><year>2005</year><volume>41</volume><fpage>190</fpage><lpage>195</lpage><pub-id pub-id-type="doi">10.1111/j.1472-765X.2005.01715.x</pub-id><?supplied-pmid 16033520?><pub-id pub-id-type="pmid">16033520</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jeon</surname><given-names>HH</given-names></name><etal/></person-group><article-title>Screening and characterization of potential <italic>Bacillus</italic> starter cultures for fermenting low-salt soybean paste (<italic>Doenjang</italic>)</article-title><source>J Microbiol Biotech.</source><year>2016</year><volume>26</volume><fpage>666</fpage><lpage>674</lpage><pub-id pub-id-type="doi">10.4014/jmb.1512.12014</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jeong</surname><given-names>SJ</given-names></name><etal/></person-group><article-title>Characterization of aprE176, a fibrinolytic enzyme from <italic>Bacillus subtilis</italic> HK176</article-title><source>J Microbiol Biotechnol.</source><year>2015</year><volume>25</volume><fpage>89</fpage><lpage>97</lpage><pub-id pub-id-type="doi">10.4014/jmb.1409.09087</pub-id><?supplied-pmid 25315053?><pub-id pub-id-type="pmid">25315053</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kurosawa</surname><given-names>Y</given-names></name><etal/></person-group><article-title>A single-dose of oral nattokinase potentiates thrombolysis and anti-coagulation profiles</article-title><source>Sci Rep-UK.</source><year>2015</year><volume>5</volume><fpage>11601</fpage><pub-id pub-id-type="doi">10.1038/srep11601</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Urano</surname><given-names>T</given-names></name><etal/></person-group><article-title>The profibrinolytic enzyme subtilisin NAT purified from <italic>Bacillus subtilis</italic> cleaves and inactivates plasminogen activator inhibitor type 1</article-title><source>J Biol Chem.</source><year>2001</year><volume>276</volume><fpage>24690</fpage><lpage>24696</lpage><pub-id pub-id-type="doi">10.1074/jbc.M101751200</pub-id><?supplied-pmid 11325965?><pub-id pub-id-type="pmid">11325965</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weng</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Nattokinase: an oral antithrombotic agent for the prevention of cardiovascular disease</article-title><source>Int J Mol Sci.</source><year>2017</year><volume>18</volume><fpage>523</fpage><pub-id pub-id-type="doi">10.3390/ijms18030523</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fujita</surname><given-names>H</given-names></name><name><surname>Yamagami</surname><given-names>T</given-names></name><name><surname>Ohshima</surname><given-names>K</given-names></name></person-group><article-title>Fermented soybean-derived water-soluble <italic>Touchi</italic> extract inhibits alpha-glucosidase and is antiglycemic in rats and humans after single oral treatments</article-title><source>J Nutr.</source><year>2001</year><volume>131</volume><fpage>1211</fpage><lpage>1213</lpage><pub-id pub-id-type="doi">10.1093/jn/131.4.1211</pub-id><pub-id pub-id-type="pmid">11285328</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moreno</surname><given-names>C</given-names></name><name><surname>Romero</surname><given-names>J</given-names></name><name><surname>Espejo</surname><given-names>R</given-names></name></person-group><article-title>Polymorphism in repeated 16S rRNA genes is a common property of type strains and environmental isolates of the genus <italic>Vibrio</italic></article-title><source>Microbiology.</source><year>2002</year><volume>148</volume><fpage>1233</fpage><lpage>1239</lpage><pub-id pub-id-type="doi">10.1099/00221287-148-4-1233</pub-id><pub-id pub-id-type="pmid">11932467</pub-id></element-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Astrup</surname><given-names>T</given-names></name><name><surname>M&#x000fc;llertz</surname><given-names>S</given-names></name></person-group><article-title>The fibrin plate method for estimating fibrinolytic activity</article-title><source>Arch Biochem Bioph.</source><year>1952</year><volume>40</volume><fpage>346</fpage><lpage>351</lpage><pub-id pub-id-type="doi">10.1016/0003-9861(52)90121-5</pub-id></element-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>SH</given-names></name><name><surname>Choi</surname><given-names>NS</given-names></name></person-group><article-title>Purification and characterization of subtilisin DJ-4 secreted by <italic>Bacillus</italic> sp. strain DJ-4 screened from <italic>Doen-Jang</italic></article-title><source>Biosci Biotech Biochem.</source><year>2000</year><volume>64</volume><fpage>1722</fpage><lpage>1725</lpage><pub-id pub-id-type="doi">10.1271/bbb.64.1722</pub-id></element-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chung.</surname><given-names>DM</given-names></name><etal/></person-group><article-title>Purification and characterization of a novel fibrinolytic enzyme from chive (<italic>Allium tuberosum</italic>)</article-title><source>Food Sci Biotechnol.</source><year>2010</year><volume>126</volume><fpage>349</fpage><lpage>355</lpage><pub-id pub-id-type="doi">10.1007/s10068-010-0050-x</pub-id></element-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>RH</given-names></name><name><surname>Peng</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>YZ</given-names></name></person-group><article-title>Highly efficient gene expression of a fibrinolytic enzyme (subtilisin DFE) in <italic>Bacillus subtilis</italic> mediated by the promoter of <italic>&#x003b1;</italic>-amylase gene from <italic>Bacillus amyloliquefaciens</italic></article-title><source>Biotechnol Letters.</source><year>2004</year><volume>26</volume><fpage>1365</fpage><lpage>1369</lpage><pub-id pub-id-type="doi">10.1023/B:BILE.0000035487.91628.9e</pub-id></element-citation></ref><ref id="CR31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sumi</surname><given-names>H</given-names></name><etal/></person-group><article-title>A novel fibrinolytic enzyme (nattokinase) in the vegetable cheese <italic>Natto</italic>; a typical and popular soybean food in the Japanese diet</article-title><source>Experientia.</source><year>1987</year><volume>43</volume><issue>11</issue><fpage>10</fpage><lpage>1</lpage><pub-id pub-id-type="doi">10.1007/bf01956052</pub-id></element-citation></ref><ref id="CR32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname><given-names>ZL</given-names></name><etal/></person-group><article-title>Construction of a 3D model of nattokinase, a novel fibrinolytic enzyme from <italic>Bacillus Natto</italic> - A novel nucleophilic catalytic mechanism for nattokinase</article-title><source>J Mol Graph Model.</source><year>2005</year><volume>23</volume><fpage>373</fpage><lpage>380</lpage><pub-id pub-id-type="doi">10.1016/j.jmgm.2004.10.002</pub-id><?supplied-pmid 15670958?><pub-id pub-id-type="pmid">15670958</pub-id></element-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahn</surname><given-names>MJ</given-names></name><etal/></person-group><article-title>Characterization of a novel fibrinolytic enzyme, <italic>BsfA</italic>, from <italic>Bacillus subtili</italic>s ZA400 in <italic>Kimchi</italic> reveals its pertinence to thrombosis treatment</article-title><source>J Microbiol Biotech.</source><year>2015</year><volume>25</volume><fpage>2090</fpage><lpage>2099</lpage><pub-id pub-id-type="doi">10.4014/jmb.1509.09048</pub-id></element-citation></ref><ref id="CR34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ko</surname><given-names>JH</given-names></name><etal/></person-group><article-title>Identification of two novel fibrinolytic enzymes from <italic>Bacillus subtilis</italic> QK02</article-title><source>Comp Biochem Phys C.</source><year>2004</year><volume>137</volume><fpage>65</fpage><lpage>74</lpage><pub-id pub-id-type="doi">10.1016/j.cca.2003.11.008</pub-id></element-citation></ref><ref id="CR35"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakamura</surname><given-names>T</given-names></name><name><surname>Yamagata</surname><given-names>Y</given-names></name><name><surname>Ichishima</surname><given-names>E</given-names></name></person-group><article-title>Nucleotide sequence of the subtilisin NAT</article-title><source>gene, aprN, of Bacillus subtilis (Natto). Biosci Biotech Biochem.</source><year>1992</year><volume>56</volume><fpage>1869</fpage><lpage>71</lpage><pub-id pub-id-type="doi">10.1271/bbb.56.1869</pub-id></element-citation></ref><ref id="CR36"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cha</surname><given-names>WS</given-names></name><etal/></person-group><article-title>Biochemical and enzymatic properties of a fibrinolytic enzyme from <italic>Pleurotus eryngii</italic> cultivated under solid-state conditions using corn cob</article-title><source>Bioresource Technol.</source><year>2010</year><volume>101</volume><fpage>6475</fpage><lpage>6481</lpage><pub-id pub-id-type="doi">10.1016/j.biortech.2010.02.048</pub-id></element-citation></ref><ref id="CR37"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Joo</surname><given-names>HS</given-names></name><etal/></person-group><article-title>Molecular cloning and functional expression of a fibrinolytic protease gene from the polychaeta, <italic>Periserrula leucophryna</italic></article-title><source>Biotechnol Boproc E.</source><year>2013</year><volume>18</volume><fpage>209</fpage><lpage>217</lpage><pub-id pub-id-type="doi">10.1007/s12257-012-0800-0</pub-id></element-citation></ref><ref id="CR38"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>T</given-names></name><etal/></person-group><article-title>Purification and biochemical characterization of a novel fibrinolytic enzyme, PSLTro01, from a medicinal animal <italic>Porcellio scaber</italic> Latreille</article-title><source>Int J Biol Macrom.</source><year>2015</year><volume>80</volume><fpage>536</fpage><lpage>546</lpage><pub-id pub-id-type="doi">10.1016/j.ijbiomac.2015.07.042</pub-id></element-citation></ref><ref id="CR39"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>X</given-names></name><etal/></person-group><article-title>Purification and biochemical characterization of a novel fibrinolytic enzyme from culture supernatant of <italic>Cordyceps militaris</italic></article-title><source>J Agr Food Chem.</source><year>2015</year><volume>63</volume><fpage>2215</fpage><lpage>2224</lpage><pub-id pub-id-type="doi">10.1021/jf505717e</pub-id><pub-id pub-id-type="pmid">25664761</pub-id></element-citation></ref><ref id="CR40"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname><given-names>JH</given-names></name><etal/></person-group><article-title>Starase: A bi-functional fibrinolytic protease from hepatic caeca of <italic>Asterina pectinifera</italic> displays antithrombotic potential</article-title><source>Biochimie.</source><year>2014</year><volume>105</volume><fpage>45</fpage><lpage>57</lpage><pub-id pub-id-type="doi">10.1016/j.biochi.2014.06.012</pub-id><?supplied-pmid 24977934?><pub-id pub-id-type="pmid">24977934</pub-id></element-citation></ref><ref id="CR41"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>W</given-names></name><etal/></person-group><article-title>Purification and characterization of a fibrinolytic enzyme produced from <italic>Bacillus</italic> sp. strain CK 11-4 screened from Chungkook-jang</article-title><source>Appl Environ Mic.</source><year>1996</year><volume>62</volume><fpage>2482</fpage><lpage>2488</lpage></element-citation></ref><ref id="CR42"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>HC</given-names></name><etal/></person-group><article-title>Purification and characterization of a novel, highly potent fibrinolytic enzyme from <italic>Paecilomyces tenuipes</italic></article-title><source>Process Biochem.</source><year>2011</year><volume>46</volume><fpage>1545</fpage><lpage>1553</lpage><pub-id pub-id-type="doi">10.1016/j.procbio.2011.04.005</pub-id></element-citation></ref><ref id="CR43"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simkhada</surname><given-names>JR</given-names></name><etal/></person-group><article-title>A novel fibrinolytic protease from <italic>Streptomyces sp</italic> CS684</article-title><source>Process Biochem.</source><year>2010</year><volume>45</volume><fpage>88</fpage><lpage>93</lpage><pub-id pub-id-type="doi">10.1016/j.procbio.2009.08.010</pub-id></element-citation></ref><ref id="CR44"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vijayaraghavan</surname><given-names>P</given-names></name><name><surname>Prakash Vincent</surname><given-names>SG</given-names></name></person-group><article-title>Medium optimization for the production of fibrinolytic enzyme by <italic>Paenibacillus</italic> sp. IND8 using response surface methodology</article-title><source>Scientific World J.</source><year>2014</year><volume>2014</volume><fpage>276942</fpage><lpage>276942</lpage><pub-id pub-id-type="doi">10.1155/2014/276942</pub-id></element-citation></ref><ref id="CR45"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>X</given-names></name><etal/></person-group><article-title>Optimization of <italic>Douchi</italic> fibrinolytic enzyme production by statistical experimental methods</article-title><source>J Huazhong Univ Sci Technolog Med Sci.</source><year>2013</year><volume>33</volume><fpage>153</fpage><lpage>158</lpage><pub-id pub-id-type="doi">10.1007/s11596-013-1089-8</pub-id><pub-id pub-id-type="pmid">23392726</pub-id></element-citation></ref><ref id="CR46"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vijayaraghavan</surname><given-names>P</given-names></name><etal/></person-group><article-title>Cow dung is a novel feedstock for fibrinolytic enzyme production from newly isolated <italic>Bacillus</italic> sp. IND7 and its application in <italic>in vitro</italic> clot lysis</article-title><source>Front Microbiol.</source><year>2016</year><volume>7</volume><fpage>361</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2016.00361</pub-id><pub-id pub-id-type="pmid">27065952</pub-id></element-citation></ref><ref id="CR47"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ying</surname><given-names>H</given-names></name><name><surname>Bo</surname><given-names>J</given-names></name><name><surname>Yoshinori</surname><given-names>M</given-names></name><name><surname>Wanmeng</surname><given-names>M</given-names></name></person-group><article-title>Purification and characterization of a novel fibrinolytic enzyme from <italic>Bacillus</italic> sp. nov. SK006 isolated from an Asian traditional fermented shrimp paste</article-title><source>Agr Food Chem.</source><year>2008</year><volume>56</volume><fpage>1451</fpage><lpage>1457</lpage><pub-id pub-id-type="doi">10.1021/jf0713410</pub-id></element-citation></ref></ref-list></back></article>